Скачать (PDF, 582KB)

Objectives:

• Promote access to life saving medicines and informed the WHO guideline Process;
• Work with all concerned parties to remove or minimize obstacles for medicines entering the market and facilitate their uptake;
• Provide partners and players in the field of SCM with reliable data to inform their decision making process.

Why:

• Limited access to information on ARV marketing authorizations by countries;
• Inform stakeholders and WHO management team in their process of making strategic decision and advocacy;
• Inform the guideline committee on the status of drug that are/will be included in the guideline;
• Inform/made available to state and non state procurement officers, donation programmes, countries using the GFATM grant (options A and B) on medicines registered in their respective country;
• Facilitate the procurement of this drugs;
• Understand some of the market drivers and procurement behavior.